Viewing StudyNCT04601610



Ignite Creation Date: 2024-05-06 @ 3:21 PM
Last Modification Date: 2024-10-26 @ 1:47 PM
Study NCT ID: NCT04601610
Status: TERMINATED
Last Update Posted: 2022-10-28
First Post: 2020-10-19

Brief Title: KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co Ltd
Organization: Jiangsu Alphamab Biopharmaceuticals Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-07
Start Date Type: ACTUAL
Primary Completion Date: 2022-05-30
Primary Completion Date Type: ACTUAL
Completion Date: 2022-05-30
Completion Date Type: ACTUAL
First Submit Date: 2020-10-19
First Submit QC Date: October 22 2020
Study First Post Date: 2020-10-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-10-26
Last Update Post Date: 2022-10-28
Last Update Post Date Type: ACTUAL